Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
1.
Allergol. immunopatol ; 44(3): 241-245, mayo-jun. 2016. graf
Article de Anglais | IBECS | ID: ibc-152080

RÉSUMÉ

BACKGROUND: Hereditary angio-oedema (HAE) is manifested by repeated episodes of localised subcutaneous or sub-mucosal oedema. Symptoms are extremely variable in frequency, localisation, and severity. Atypical or mild clinical symptoms of the disease may lead to erroneous diagnosis, causing diagnostic delay. The goal of this study was to assess how diagnostic delay has changed over 33 years at a single referral centre. METHODS: We analysed diagnostic delay and first symptoms of HAE in patients who were diagnosed at an immunology department between 1980 and 2013. Patient's records were analysed. RESULTS: The median diagnostic delay in 77 HAE type 1 and 2 patients was seven (range, 0-42) years. The difference observed in diagnostic delay between probands (18 [0-42] years) and others (1 [0-37] year) was significant (p < 0.001). Our data show a significant negative correlation between the length of diagnostic delay and the year of diagnosis in our group of patients (p = 0.024). The median age of first symptoms among all HAE patients (N = 64) was 17 (1-40) years. The first symptoms of HAE in 64 patients were analysed. Twenty-six patients had abdominal, seventeen peripheral, five facial, two urogenital, and three had laryngeal oedema as the first manifestation of the disease. The last death that was attributed to HAE was in 1977. CONCLUSIONS: Our observations demonstrate improved awareness of HAE among physicians, as documented by the significant decrease in diagnostic delay. It is believed that earlier treatment will improve patient quality of life and life expectancy


No disponible


Sujet(s)
Humains , Mâle , Femelle , Nourrisson , Enfant d'âge préscolaire , Enfant , Adolescent , Jeune adulte , Adulte , Angio-oedèmes héréditaires/diagnostic , Angio-oedèmes héréditaires/prévention et contrôle , Angio-oedèmes héréditaires/thérapie , Inhibiteur de la protéine C/effets indésirables , Inhibiteur de la protéine C/déficit , Diagnostic précoce , Diagnostic différentiel , Qualité de vie , Immunodiffusion/instrumentation , Immunodiffusion/méthodes , Néphélométrie et turbidimétrie/instrumentation , Néphélométrie et turbidimétrie/méthodes , Oedème laryngé/diagnostic , Oedème laryngé/thérapie , Études rétrospectives , République tchèque
2.
Fertil Steril ; 88(4 Suppl): 1049-57, 2007 Oct.
Article de Anglais | MEDLINE | ID: mdl-17434507

RÉSUMÉ

OBJECTIVE: To investigate the mechanisms responsible for the testicular abnormalities and infertility of previously generated male protein C inhibitor (PCI)-deficient mice. DESIGN: Determination of the localization of PCI in the reproductive organs of wild-type males. Generation of double knockout mice lacking the protease inhibitor PCI and one plasminogen activator, either urokinase (uPA) or tissue plasminogen activator (tPA), both of which are PCI-target proteases. SETTING: Animal research and histologic analysis. ANIMAL(S): Male mice of desired genotype. INTERVENTION(S): Fertility testing of double knockout mice. MAIN OUTCOME MEASURE(S): Infertility of PCI(-/-)uPA(-/-) and PCI(-/-)tPA(-/-) double knockout mice. RESULT(S): In the testes of wild-type males PCI was detected in spermatocytes of prophase I, as well as in late spermatids and mature spermatozoa, but absent from somatic cells. All PCI(-/-) uPA(-/-) and PCI(-/-) tPA(-/-) male mice were infertile and histologic analysis of testis showed similar alterations as previously described for PCI(-/-) mice. CONCLUSION(S): The abnormal spermatogenesis of PCI (plasminogen activator inhibitor-3)-deficient mice cannot be rescued by single plasminogen activator knockout.


Sujet(s)
Fécondité , Inhibiteur de la protéine C/analyse , Inhibiteur de la protéine C/génétique , Spermatogenèse , Testicule/composition chimique , Animaux , Différenciation cellulaire/génétique , Femelle , Fécondité/génétique , Infertilité masculine/génétique , Infertilité masculine/métabolisme , Mâle , Souris , Souris knockout , Inhibiteur de la protéine C/déficit , Spermatogenèse/génétique , Testicule/cytologie , Testicule/métabolisme
3.
J Clin Invest ; 106(12): 1531-9, 2000 Dec.
Article de Anglais | MEDLINE | ID: mdl-11120760

RÉSUMÉ

Protein C inhibitor (PCI) is a nonspecific, heparin-binding serpin (serine protease inhibitor) that inactivates many plasmatic and extravascular serine proteases by forming stable 1:1 complexes. Proteases inhibited by PCI include the anticoagulant activated protein C, the plasminogen activator urokinase, and the sperm protease acrosin. In humans PCI circulates as a plasma protein but is also present at high concentrations in organs of the male reproductive tract. The biological role of PCI has not been defined so far. However, the colocalization of high concentrations of PCI together with several of its target proteases in the male reproductive tract suggests a role of PCI in reproduction. We generated mice lacking PCI by homologous recombination. Here we show that PCI(-/-) mice are apparently healthy but that males of this genotype are infertile. Infertility was apparently caused by abnormal spermatogenesis due to destruction of the Sertoli cell barrier, perhaps due to unopposed proteolytic activity. The resulting sperm are malformed and are morphologically similar to abnormal sperm seen in some cases of human male infertility. This animal model might therefore be useful for analyzing the molecular bases of these human conditions.


Sujet(s)
Délétion de gène , Infertilité masculine , Inhibiteur de la protéine C/génétique , Inhibiteur de la protéine C/métabolisme , Spermatogenèse , Animaux , Modèles animaux de maladie humaine , Femelle , Fécondation , Fécondation in vitro , Ciblage de gène , Histocytochimie , Mâle , Souris , Souris knockout , Microscopie électronique , Oligopeptides/métabolisme , Ovaire , Inhibiteur de la protéine C/déficit , ARN messager/analyse , ARN messager/génétique , Serine endopeptidases/métabolisme , Spermatozoïdes/métabolisme , Spermatozoïdes/anatomopathologie , Testicule/enzymologie , Testicule/métabolisme , Testicule/anatomopathologie
4.
Orv Hetil ; 140(43): 2405-7, 1999 Oct 24.
Article de Hongrois | MEDLINE | ID: mdl-10624112

RÉSUMÉ

The incidence of malignant lymphoma cases in constantly growing. Therefore it is worth-while to consider its presence even in cases where the symptoms do not give a clear indication of the disease. Two cases with angiooema being rare and not carachteristic signs for malignant lymphoma are reported. The authors discuss the supposed paraneoplastic patomechanism in malignant lymphoma, i.e. the possible role of C' 1 inhibition. In the view at the cases discussed the authors propose to consider the possible diagnosis of malignant lymphoma if unexplained angiooedema is present.


Sujet(s)
Angioedème/étiologie , Lymphomes/complications , Sujet âgé , Angioedème/diagnostic , Humains , Lymphomes/diagnostic , Mâle , Inhibiteur de la protéine C/déficit
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...